I would guess so. From my understanding people in the SAS program either paid nothing or very little. If they get provisional approval to sell then this will be to generate profit so I imagine it will cost a fair bit as it will not be covered by the government pharmaceutical benefit scheme or health insurance. I could be wrong but that's my understanding.
PPS completed 12 injection course, page-74
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.010(3.45%) |
Mkt cap ! $97.94M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.5¢ | 27.5¢ | $444.5K | 1.482M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19907 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 3330 | 1 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |